Evaluation of the Effect of Reiki on Pain After Spinal Fusion
REDAL
1 other identifier
interventional
60
1 country
1
Brief Summary
This study involves patients undergoing lumbar spine surgery (lumbar arthrodesis). It compares the effects of Reiki, an energy-based therapy, with conventional approaches to relieve postoperative pain. The goal is to determine whether this non-drug method can help reduce pain, limit the use of painkillers, and enhance patient comfort during recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2025
CompletedFirst Posted
Study publicly available on registry
July 14, 2025
CompletedStudy Start
First participant enrolled
September 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 28, 2026
February 4, 2026
February 1, 2026
9 months
July 2, 2025
February 3, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
pain will be assessed at Day 15 using the VAS ( Visial Analog Scale)
The Visual Analog Scale is a subjective measurement tool commonly used to assess the intensity of pain. It consists of a horizontal 10-centimeter line on which the patient marks a point that reflects their experience. Minimum and maximum values: 0 = complete absence of the symptom 10 = the most severe imaginable intensity of the symptom Score interpretation: Higher scores indicate greater symptom intensity Lower scores indicate lesser intensity
DAY 15
Secondary Outcomes (5)
Quality of life will be assessed using the SF12
DAY 30
Daily pain intensity will be reported
from Day 1 to Day 30
evaluation of patient's overall satisfaction and treatment response
at Day 30
Assessment of the condition of the scar at the lumbar level
at Day 15 and Day 30
antalgic consumption will be reported
from day 1 to day 30
Study Arms (2)
standard treatment (analgesic + kinesitherapy sessions) + Treatment session (Reiki)
EXPERIMENTALtreatment with reiki session
standard treatment (analgesic + kinesitherapy sessions) + Treatment session (Sham)
PLACEBO COMPARATORtreatment with sham session
Interventions
Sham sessions for 30 minutes, on D-7 before the surgery and on D15 after the surgery,
Reiki sessions for 30 minutes, on Day-7 before the surgery and on D15 after the surgery
Eligibility Criteria
You may qualify if:
- \- Subject aged 18 years or older;
- Referred for a lumbar fusion of up to 3 levels.
- Absence of participation in another clinical study.
- Subject affiliated with a social security scheme or beneficiary of such a scheme
You may not qualify if:
- Neuropathic patient
- Presence of neuropathic pain
- Diagnosis of fibromyalgia
- Received therapeutic touch, polarity therapy, or professional massage therapy in the past four weeks
- Unable to undergo medical follow-up for the study
- Adult subject protected by law, under guardianship or trusteeship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clinique Bizetlead
Study Sites (1)
Clinique Bizet
Paris, 75016, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
georges ABI LAHOUD, Professeur
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 2, 2025
First Posted
July 14, 2025
Study Start
September 9, 2025
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
July 28, 2026
Last Updated
February 4, 2026
Record last verified: 2026-02